COR2ED Medical Education
By COR2ED
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by COR2ED
Category: Science
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 2
Reviews: 0
Episodes: 85
Description
Our COR2ED podcast brings together world-renowned medical experts to discuss and provide clear guidance on the latest scientific and clinical insights in various therapeutic areas, including oncology, cardiology, hemostasis, rare diseases, hemato-oncology, and endocrinology.
At COR2ED, we are committed to providing balanced and evidence-based independent medical education to support healthcare professionals in enhancing patient care. Many of our podcast episodes are created in collaboration with medical societies and patient advocacy groups.
www.cor2ed.com
| Episode | Date |
|---|---|
|
Choose your podcast channel: oncology, obstetrics & gynecology, hematology and rare diseases
|
Mar 15, 2025 |
|
Diagnosis and management of short stature patients (Video)
|
Dec 04, 2023 |
|
Diagnosis and management of short stature patients
|
Dec 04, 2023 |
|
Gene therapy and gene-modified cell therapy in rare diseases
|
Nov 29, 2023 |
|
Perioperative Thromboprophylaxis Revisited
|
Nov 27, 2023 |
|
Prostate Cancer: Pre-Analytical Phase Challenges and Biomarker Testing
|
Nov 21, 2023 |
|
Prostate Cancer: Pre-Analytical Phase Challenges and Biomarker Testing (Video)
|
Nov 20, 2023 |
|
VTE: how long should anti-thrombotic treatment be?
|
Oct 25, 2023 |
|
Treatment of severe PPH – Learnings from clinical practice
|
Oct 23, 2023 |
|
IUD Placement: How to Reduce Anxiety and Pain for Patients
|
Oct 11, 2023 |
|
Cancer and Thrombosis
|
Sep 25, 2023 |
|
Severe PPH – Definitions and Real-World Incidence
|
Sep 21, 2023 |
|
Advanced HCC: 2nd line treatment selection and the right time to switch
|
Sep 03, 2023 |
|
Breast Cancer: Oral SERDs in ER+ breast cancer. Episode 3 - rare cases & treatment challenges
|
Aug 30, 2023 |
|
Monitoring anticoagulation: yes or no?
|
Aug 23, 2023 |
|
An introduction to molecular testing: what and when across the patient journey
|
Jul 26, 2023 |
|
Breast Cancer: Oral SERDs in ER+ breast cancer. Episode 2 - treatment selection and beyond
|
Jul 26, 2023 |
|
Metastatic gastric and GEJ cancers: clinical case discussions ep.2
|
Jul 13, 2023 |
|
Non-metastatic gastric and GEJ cancers: clinical case discussions ep.1
|
Jul 13, 2023 |
|
PBC Highlights from EASL 2023 – episode 2
|
Jun 29, 2023 |
|
PBC Highlights from EASL 2023: Episode 1
|
Jun 28, 2023 |
|
Breast Cancer : Oral SERDs in ER+ breast cancer. Episode 1 - efficacy and safety and treatment landscape
|
Jun 20, 2023 |
|
Treatment Intensification in mCSPC - The Nurse Perspective
|
Jun 13, 2023 |
|
Treatment sequencing in advanced mCRC patients
|
Apr 26, 2023 |
|
Case-based discussion on which mCSPC patients benefit from early treatment intensification
|
Apr 05, 2023 |
|
Overview of efficacy and safety data of combination therapy with PARPi and NHAs
|
Mar 27, 2023 |
|
Advanced HCC and not eligible for IO – what are the treatment options?
|
Mar 14, 2023 |
|
PARPi and NHA combination therapy for patients with mCRPC – a US and EU perspective
|
Feb 15, 2023 |
|
Clinical implementation of PARPi monotherapy for prostate cancer patients – a US and EU perspective
|
Feb 15, 2023 |
|
Update from ASCO GI 2023 Ep 2: lower GI cancer highlights
|
Feb 02, 2023 |
|
Update from ASCO GI 2023: upper GI cancer highlights
|
Jan 30, 2023 |
|
Gynaecological considerations in Women with Bleeding Disorders
|
Jan 16, 2023 |
|
SARCOMA updates from CTOS 2022
|
Jan 05, 2023 |
|
Why iron matters in women with bleeding disorders
|
Nov 25, 2022 |
|
The role of SSA at progression – to continue or not?
|
Nov 18, 2022 |
|
Treating von Willebrand Disease: Does the Type Matter?
|
Nov 16, 2022 |
|
HCC updates from ILCA and ESMO congressess 2022
|
Oct 06, 2022 |
|
GI CONNECT Update from ESMO 2022 Ep 2: upper GI cancer highlights
|
Sep 27, 2022 |
|
GI CONNECT Update from ESMO 2022 Ep 1: lower GI cancer highlights
|
Sep 20, 2022 |
|
ASBMR 2022 Rare Bone Disease Highlights: Episode 3
|
Sep 15, 2022 |
|
ASBMR 2022 Rare Bone Disease Highlights: Episode 2
|
Sep 14, 2022 |
|
ASBMR 2022 Rare Bone Disease Highlights: Episode 1
|
Sep 12, 2022 |
|
What to Expect When They’re Expecting: Bleeding Disorders and Pregnancy
|
Sep 07, 2022 |
|
Flexible Dosing of Oral Treatments in mCRC
|
Sep 05, 2022 |
|
Clinical Implications: updated Bone Sarcoma guidelines
|
Sep 01, 2022 |
|
Role of immunotherapy beyond advanced HCC
|
Aug 17, 2022 |
|
Changing paradigms of haemophilia care in Europe
|
Aug 02, 2022 |
|
Prostate Cancer Highlights from ASCO GU, ASCO and EAUN 2022
|
Jul 28, 2022 |
|
Shared decision-making in nmCRPC
|
Jul 11, 2022 |
|
Timing of ARSI and taxanes for mCSPC
|
Jul 05, 2022 |
|
PBC highlights from ILC 2022: ep.2
|
Jul 04, 2022 |
|
PBC Highlights from ILC 2022: Ep. 1
|
Jun 28, 2022 |
|
Management of Skin Toxicity with Multikinase Inhibitors
|
Jun 08, 2022 |
|
Immune tolerance induction in the era of emicizumab
|
May 03, 2022 |
|
High-Risk Cytogenetics in MM: Choosing the Best Treatment Regimen Ep 3
|
Mar 16, 2022 |
|
Prostate Cancer Highlights from ASCO GU 2022
|
Mar 08, 2022 |
|
Prophylaxis in children with haemophilia
|
Mar 03, 2022 |
|
Key topics in HCC discussed at ASCO GI & EASL liver cancer summit 2022
|
Feb 28, 2022 |
|
PARP inhibitors in prostate cancer: Management of adverse events and the importance of communication with patients
|
Feb 10, 2022 |
|
Inhibidores de PARP en cáncer de próstata: lo que las enfermeras necesitan saber
|
Feb 07, 2022 |
|
PARP inhibitors in prostate cancer: What nurses need to know
|
Feb 07, 2022 |
|
Genetic testing and PARP inhibitors in prostate cancer
|
Jan 28, 2022 |
|
TRK fusion-positive lung cancers
|
Jan 10, 2022 |
|
VEGFR-TKIs alone or in combination with immune checkpoint inhibitors in clinical practice for the treatment of HCC
|
Dec 02, 2021 |
|
The role of VEGFR-TKIs in the treatment of advanced RCC alone or in combination
|
Nov 30, 2021 |
|
Current and Future Therapeutic Approaches in Colorectal and Gastric Cancer: Future Developments - Ep 3
|
Oct 21, 2021 |
|
Current and Future Therapeutic Approaches in Colorectal and Gastric Cancer: Immunotherapy - Ep 2
|
Oct 21, 2021 |
|
Current and Future Therapeutic Approaches in Colorectal and Gastric Cancer: Targeted Therapy - Ep 1
|
Oct 21, 2021 |
|
Choosing the Best Treatment Regimen in Multiple Myeloma: Episode 2 – the Relapsed/Refractory Setting
|
Oct 21, 2021 |
|
The use of VEGFR-TKIs monotherapy in the treatment of unresectable or advanced HCC in 1L setting
|
Oct 19, 2021 |
|
Choosing the Best Treatment Regimen in Multiple Myeloma: Episode 1 - the Newly Diagnosed Setting
|
Oct 13, 2021 |
|
ASBMR 2021 Rare Bone Disease Highlights: Episode 4
|
Oct 08, 2021 |
|
ASBMR 2021 Rare Bone Disease Highlights: Episode Three
|
Oct 05, 2021 |
|
ASBMR 2021 Rare Bone Disease Highlights from Day Two
|
Oct 03, 2021 |
|
ASBMR 2021 Rare Bone Disease Highlights from Day One
|
Oct 02, 2021 |
|
Highlights from ILCA and ESMO 2021 in HCC
|
Sep 30, 2021 |
|
Diagnosis and treatment of TRK fusion-positive GI cancers
|
Sep 23, 2021 |
|
Nurse management of AEs in patients receiving VEGFR-TKIs
|
Sep 08, 2021 |
|
Optimising VEGFR-TKIs (MKIs) in Differentiated Thyroid Cancer
|
Sep 06, 2021 |
|
Women & Girls Bleed Too: Managing Bleeding Disorders - Episode 3
|
Jul 29, 2021 |
|
Women & Girls Bleed Too: Diagnosing Bleeding Disorders - Episode 2
|
Jul 22, 2021 |
|
Women & Girls Bleed Too: Recognising Bleeding Disorders - Episode 1
|
Jul 19, 2021 |
|
Hepatocellular carcinoma highlights from ASCO and WCGIC 2021
|
Jul 16, 2021 |
|
Radiopharmaceuticals in prostate cancer - PSMA Theranostics episode 2
|
May 12, 2021 |
|
Radiopharmaceuticals in prostate cancer - radium-223 episode 1
|
May 12, 2021 |